Vanguard Group Inc. reduced its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 0.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,591,218 shares of the oil and gas company's stock after selling 28,123 shares during the quarter. Vanguard Group Inc. owned approximately 11.91% of Core Laboratories worth $96,784,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Assetmark Inc. bought a new position in Core Laboratories in the fourth quarter valued at $26,000. Smartleaf Asset Management LLC grew its holdings in shares of Core Laboratories by 173.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock valued at $35,000 after acquiring an additional 1,293 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of Core Laboratories by 2,688.5% in the fourth quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock valued at $42,000 after acquiring an additional 2,339 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in Core Laboratories during the fourth quarter worth about $149,000. Finally, Isthmus Partners LLC boosted its position in Core Laboratories by 5.6% during the fourth quarter. Isthmus Partners LLC now owns 11,219 shares of the oil and gas company's stock valued at $194,000 after purchasing an additional 599 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.
Core Laboratories Stock Performance
Core Laboratories stock traded down $0.01 during trading hours on Tuesday, hitting $12.14. The company had a trading volume of 52,492 shares, compared to its average volume of 382,632. Core Laboratories Inc. has a one year low of $10.14 and a one year high of $25.13. The firm has a market cap of $567.10 million, a PE ratio of 18.39, a PEG ratio of 0.99 and a beta of 1.99. The firm has a 50-day moving average of $14.91 and a 200 day moving average of $17.61. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71.
Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, hitting the consensus estimate of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. On average, sell-side analysts expect that Core Laboratories Inc. will post 0.96 earnings per share for the current year.
Core Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Monday, February 10th were paid a $0.01 dividend. The ex-dividend date was Monday, February 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.33%. Core Laboratories's dividend payout ratio (DPR) is presently 6.06%.
Wall Street Analyst Weigh In
Separately, Citigroup raised shares of Core Laboratories from a "sell" rating to a "neutral" rating and raised their target price for the company from $15.00 to $16.00 in a research note on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating and four have issued a hold rating to the company's stock. According to data from MarketBeat.com, Core Laboratories currently has an average rating of "Hold" and a consensus target price of $17.50.
Get Our Latest Analysis on Core Laboratories
Core Laboratories Company Profile
(
Free Report)
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Further Reading
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
